90 related articles for article (PubMed ID: 2671436)
1. [Specific cardiomyopathy caused by high dose cyclophosphamide immediately after bone marrow transplantation].
Mitsui H; Kitayama H; Yamagami T; Osuga Y; Teshima H; Ueda T; Hiraoka A; Nakamura H; Shibata H; Masaoka T
Rinsho Ketsueki; 1989 Mar; 30(3):387-91. PubMed ID: 2671436
[TBL] [Abstract][Full Text] [Related]
2. Unrelated allogeneic bone marrow transplantation using high-dose busulfan and cyclophosphamide (BU-CY) for the preparative regimen.
Sahebi F; Copelan E; Crilley P; Bolwell B; Avalos B; Klein J; Territo M; Gajewski J
Bone Marrow Transplant; 1996 May; 17(5):685-9. PubMed ID: 8733682
[TBL] [Abstract][Full Text] [Related]
3. Massive pleural effusion attributed to high-dose cyclophosphamide during conditioning for BMT.
Schaap N; Raymakers R; Schattenberg A; Ottevanger JP; de Witte T
Bone Marrow Transplant; 1996 Jul; 18(1):247-8. PubMed ID: 8832029
[TBL] [Abstract][Full Text] [Related]
4. Total body irradiation and cyclophosphamide is a conditioning regimen for unrelated bone marrow transplantation in a patient with chronic myelogenous leukemia and renal failure on hemodialysis.
Bischoff ME; Blau W; Wagner T; Wagenmann W; Dörner O; Basara N; Fauser AA
Bone Marrow Transplant; 1998 Sep; 22(6):591-3. PubMed ID: 9758350
[TBL] [Abstract][Full Text] [Related]
5. Cardiac involvement in bone marrow transplantation: electrocardiographic changes, arrhythmias, heart failure and autopsy findings.
Kupari M; Volin L; Suokas A; Timonen T; Hekali P; Ruutu T
Bone Marrow Transplant; 1990 Feb; 5(2):91-8. PubMed ID: 2138043
[TBL] [Abstract][Full Text] [Related]
6. Total body irradiation and high-dose cyclophosphamide, BCNU and VP-16 (CBV) as a new preparatory regimen for allogeneic bone marrow transplantation in patients with advanced hematologic malignancies.
Wu DP; Milpied N; Moreau P; Mechinaud-Lacroix F; Mahe B; Le Tortorec S; Rapp MJ; Bourdin S; Mahe JM; Harousseau JL
Bone Marrow Transplant; 1994 Nov; 14(5):751-7. PubMed ID: 7889008
[TBL] [Abstract][Full Text] [Related]
7. Eosinophilia after allogeneic bone marrow transplantation using the busulfan and cyclophosphamide preparative regimen.
Kalaycioglu ME; Bolwell BJ
Bone Marrow Transplant; 1994 Jul; 14(1):113-5. PubMed ID: 7951097
[TBL] [Abstract][Full Text] [Related]
8. Successful one antigen mismatched bone marrow transplant for chronic myeloid leukemia (CML) after two failed syngeneic transplants.
Manna A; Bacigalupo A; Palazzo G; Amurri B; Maggi A; Mazza P
Bone Marrow Transplant; 1999 May; 23(10):1085-6. PubMed ID: 10373077
[TBL] [Abstract][Full Text] [Related]
9. Allogeneic peripheral blood stem cell transplantation in patients with early-phase hematologic malignancy: a retrospective comparison of short-term outcome with bone marrow transplantation.
Lemoli RM; Bandini G; Leopardi G; Rosti G; Bonini A; Fortuna A; Rondelli D; Mangianti S; Motta MR; Rizzi S; Tassi C; Cavo M; Remiddi C; Curti A; Conte R; Tura S
Haematologica; 1998 Jan; 83(1):48-55. PubMed ID: 9542323
[TBL] [Abstract][Full Text] [Related]
10. High doses of cyclophosphamide, etoposide and total body irradiation followed by autologous stem cell transplantation in the management of patients with chronic myelogenous leukemia.
Kantarjian HM; Talpaz M; Andersson B; Khouri I; Giralt S; Rios MB; Champlin R; Hester J; Deisseroth AB
Bone Marrow Transplant; 1994 Jul; 14(1):57-61. PubMed ID: 7951120
[TBL] [Abstract][Full Text] [Related]
11. [Myocardial hemorrhage due to high-dose cyclophosphamide treatment in a case of non-Hodgkin's lymphoma].
Yano S; Asai O; Kuraishi Y; Kobayashi T; Fujii T; Hirano A; Mizunuma N; Tada N; Dobashi N; Inamoto Y
Rinsho Ketsueki; 1993 Mar; 34(3):373-7. PubMed ID: 8479091
[TBL] [Abstract][Full Text] [Related]
12. Risk factors in bone marrow transplant recipients with leukaemia. Increased relapse risk in patients treated with ciprofloxacin for gut decontamination.
Carlens S; Ringdén O; Aschan J; Hägglund H; Ljungman P; Mattsson J; Remberger M
Clin Transplant; 1998 Apr; 12(2):84-92. PubMed ID: 9575394
[TBL] [Abstract][Full Text] [Related]
13. [Autologous bone marrow transplantation for patients with chronic myelogenous leukemia after in vitro purging of the graft with bcr/abl antisense oligodeoxynucleotides].
Sun J; Wu B; Liu Q; Feng R; Liu X; Meng F; Zhou S
Zhonghua Xue Ye Xue Za Zhi; 2000 Aug; 21(8):400-2. PubMed ID: 11877009
[TBL] [Abstract][Full Text] [Related]
14. Resolution of psoriasis following allogeneic bone marrow transplantation for chronic myelogenous leukemia: case report and review of the literature.
Kanamori H; Tanaka M; Kawaguchi H; Yamaji S; Fujimaki K; Tomita N; Fujisawa S; Ishigatsubo Y
Am J Hematol; 2002 Sep; 71(1):41-4. PubMed ID: 12221673
[TBL] [Abstract][Full Text] [Related]
15. Results of allogeneic bone marrow transplant in chronic myeloid leukaemia following conditioning with busulfan and cyclophosphamide.
Saikia TK; Advani SH; Parikh PM; Bapna A; Somjee S; Mukhopadhyay A; Gopal R; Nair CN
J Assoc Physicians India; 1999 Aug; 47(8):770-3. PubMed ID: 10778619
[TBL] [Abstract][Full Text] [Related]
16. A comparison of chimerism and minimal residual disease between four different allogeneic transplantation methods in patients with chronic myelogenous leukemia in first chronic phase.
Elmaagacli AH; Runkel K; Steckel N; Opalka B; Trenschel R; Seeber S; Schaefer UW; Beelen DW
Bone Marrow Transplant; 2001 Apr; 27(8):809-15. PubMed ID: 11477437
[TBL] [Abstract][Full Text] [Related]
17. Fate of chronic myeloid leukemia patients treated with allogeneic bone marrow transplantation or chemotherapy and/or interferon at a single center: long-term results.
Gaziev D; Galimberti M; Polchi P; Angelucci E; Giardini C; Baronciani D; Andreani M; Persini B; Erer B; Sodani P; Manna M; Nicolini G; Visani G; Lucarelli G;
Bone Marrow Transplant; 2002 Jan; 29(1):1-8. PubMed ID: 11840137
[TBL] [Abstract][Full Text] [Related]
18. [A new radiation-free conditioning in bone marrow transplantation and dibromo-mannitol therapy in chronic myeloid leukemia].
Kelemen E; Dénes R; Barta A; Masszi T; Reményi P; Pálóczi K; Bátai A; Torbágyo E; Sipos A; Lengyel L; Jakab K; Gyódi E; Réti M; Földi J; Páldi-Haris P; Manuel A; Fekete S; Török J; Hoffer I; Jakab J; Váradi G; Petrányi G
Orv Hetil; 1998 Aug; 139(34):2003-1; discussion 2011-2. PubMed ID: 9745304
[TBL] [Abstract][Full Text] [Related]
19. Treatment of Ph1-positive chronic myelogenous leukemia in children: comparison between allogeneic bone marrow transplantation and conventional chemotherapy. Spanish Working Party for BMT in Children (GETMON).
Muñoz A; Bureo E; Ortega JJ; Richard C; Olivé T; Maldonado MS; Madero L; Díaz MA
Haematologica; 1998 Nov; 83(11):981-4. PubMed ID: 9864916
[TBL] [Abstract][Full Text] [Related]
20. Detection of minimal residual disease and persistence of host-type hematopoiesis: a study in 28 patients after sex-mismatched, non-T cell-depleted allogeneic bone marrow transplantation for Philadelphia-chromosome positive chronic myelogenous leukemia.
Elmaagacli AH; Becks HW; Beelen DW; Stockova J; Bützler R; Opalka B; Schaefer UW
Bone Marrow Transplant; 1995 Dec; 16(6):823-9. PubMed ID: 8750276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]